Injections given on site
Kowdley 1 , Amarita Randhawa 2 , Jing Li 2 , Hiral Patel 2 , Christopher Gasink 2 , Sangeeta Sawhney 2 and Scott Isaacs 3 , (1)Liver Institute Northwest, (2)Intercept Pharmaceuticals, Inc., Morristown, NJ, (3)Emory University School of Medicine Background: Type 2 diabetes mellitus (T2D) is a common comorbidity associated with nonalcoholic steatohepatitis (NASH)
Unlike other companies that charge additional fees for higher doses, NiceRx charges the same price for all doses
Analysts expect this wave to expand the addressable market dramatically, as millions of patients priced out of branded GLP-1s finally gain access
Cellular Wellness
Current statistics indicate that fewer than 10% of those diagnosed with AUD receive any form of treatment, and only 2% of those who do utilize evidence-based pharmacotherapy